Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?

Direct oral anticoagulants against activated factor X and thrombin were the last milestone in thrombosis treatment. Step by step, they replaced antivitamin K and heparins in most of their therapeutic indications. As effective as the previous anticoagulant, the decreased but persistent risk of bleedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Poenou, Géraldine, Heestermans, Marco, Lafaie, Ludovic, Accassat, Sandrine, Moulin, Nathalie, Rodière, Alexandre, Petit, Bastien, Duvillard, Cécile, Mismetti, Patrick, Bertoletti, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572808/
https://www.ncbi.nlm.nih.gov/pubmed/37833881
http://dx.doi.org/10.3390/ijms241914433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572808/
https://www.ncbi.nlm.nih.gov/pubmed/37833881
http://dx.doi.org/10.3390/ijms241914433

Ejemplares similares